EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY-NC-ND 4.0

Pertussis clinical profile shift, severity, prediction in a tertiary hospital: A comparative study before, during, and after COVID-19 in Southern China

Shufeng Tian, Yulan Chen, Qiru Su, Biao Sun, Zengrui Lin, Yuchun Long, Hongmei Wang, Cuijuan Liao, Ying Zhang, Jinjun Zheng, Lvjun Chen, Song Guan und 5 weitere

Journal of Infection and Public Health · 2025

DOI: 10.1016/j.jiph.2024.102610 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Journal of Infection and Public Health, 2025. Verfasst von Shufeng Tian und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Shenzhen Children's Hospital, Shenzhen, China. Hauptthemen laut MEDLINE: COVID-19, Tertiary Care Centers, Whooping Cough, SARS-CoV-2. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Sanming Project of Medicine in Shenzhen, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: To analyze the epidemiological characteristics, clinical manifestations, antimicrobial resistance and develop a predictive model for severe pertussis spanning five years - before, during, and after the COVID-19 pandemic - in Shenzhen children's hospital in southern China, aiming to provide insights into the pandemic impact and control measures on the pertussis disease profile. METHODS: Demographic, clinical, vaccination, and laboratory data were collected for patients who tested positive for pertussis by polymerase chain reaction and/or culture from January 1, 2019, to March 30, 2024. Analysis included changes in demographic and clinical features, indicators of severe cases, and resistance patterns over the study period. RESULTS: During this period, 3963 patients were diagnosed, with 79 severe (PICU admitted) cases; 1433 isolates underwent antimicrobial susceptibility testing. In late 2023, pertussis cases began to increase. From 2019 to 2024, the proportion of cases among 4-6 year olds rose from 4.9 % to 28.6 %, and among 7-11 year olds from 0.7 % to 21.2 %. Macrolide resistance surged from 46.5 % in 2019 to 97.3 % in 2024, with 80 % of resistant hospitalized cases initially treated with macrolides. Clinical severity and co-infection increased post-pandemic, with a larger number of cases necessitating antibiotic changes and enhanced supportive care. Vaccination protected against severe disease. Indicators such as white blood cell count, lymphocyte to neutrophil ratio, platelet count, cyanosis and pneumonia predicted disease severity. CONCLUSIONS: Post-pandemic, pertussis cases shifted from infants to school-aged children, with increased clinical severity and high macrolide resistance. Urgent measures are needed to optimize vaccination schedules and develop management strategies addressing and changing epidemiological patterns.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Tertiary Care CentersWhooping CoughSARS-CoV-2HumansChinaChild, PreschoolChildFemaleMaleInfantSeverity of Illness IndexAnti-Bacterial AgentsAdolescentDrug Resistance, BacterialBordetella pertussisMicrobial Sensitivity Tests

Stichwörter der Autor:innen

Bordetella pertussisCOVID-19 pandemicEpidemiological and clinical changesMacrolide resistanceRisk factors

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Infectious Diseases, Shenzhen Children's Hospital, Shenzhen, China.
  • Department of Infectious Diseases, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, National Medical Centre for Infectious Diseases, Huashan Hospital, Shanghai Medical College, Fudan Univ…
  • Department of Infectious Diseases, Shenzhen Children's Hospital, Shenzhen, China. Electronic address: szsetyydeng@sina.com.

Förderung

  • National Natural Science Foundation of China
  • Sanming Project of Medicine in Shenzhen
  • National Key Research and Development Program of China

Zitieren

APA

Tian, S., Chen, Y., Su, Q., Sun, B., Lin, Z., Long, Y., Wang, H., Liao, C., Zhang, Y., Zheng, J., Chen, L., Guan, S., Wang, S., Xu, X., Ai, J., Zhang, W., & Deng, J. (2025). Pertussis clinical profile shift, severity, prediction in a tertiary hospital: A comparative study before, during, and after COVID-19 in Southern China. Journal of Infection and Public Health. https://doi.org/10.1016/j.jiph.2024.102610

Vancouver

Tian S, Chen Y, Su Q, Sun B, Lin Z, Long Y, et al. Pertussis clinical profile shift, severity, prediction in a tertiary hospital: A comparative study before, during, and after COVID-19 in Southern China. Journal of Infection and Public Health. 2025. doi:10.1016/j.jiph.2024.102610

BibTeX
@article{Tian2025,
  author = {Tian, Shufeng and Chen, Yulan and Su, Qiru and Sun, Biao and Lin, Zengrui and Long, Yuchun and Wang, Hongmei and Liao, Cuijuan and Zhang, Ying and Zheng, Jinjun and Chen, Lvjun and Guan, Song and Wang, Sen and Xu, Xinlei and Ai, Jingwen and Zhang, Wenhong and Deng, Jikui},
  title = {Pertussis clinical profile shift, severity, prediction in a tertiary hospital: A comparative study before, during, and after COVID-19 in Southern China},
  journal = {Journal of Infection and Public Health},
  year = {2025},
  doi = {10.1016/j.jiph.2024.102610}
}
Kostenlos starten →